Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (Thrive)

HEALTH AND HUMAN SERVICES, DEPARTMENT OF United States has Released a tender for Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (Thrive) in Pharmaceuticals. The tender was released on Oct 02, 2025.

Country - United States

Summary - Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (Thrive)

Deadline - login to view

GT reference number - 119306408

Product classification - Anthelmintics

Organization Details:

  Address - United States

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 119306408

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The purpose of this amendment is to: 1. Extend the registration deadline for lightning talks and sidebars to October 2, 2025 at 08:59AM ET. 2. Extend the available days/hours for lightning talks and sidebars. Lightning talks and sidebars slots will now be available on October 3. 2025. Slots for the October 3rd lightning talks and sidebars will be available between 11:00AM ET to 2:00PM ET. In addition, slots for the October 2nd sidebars will now be available between 11:00AM ET and 7:00PM ET. Please see the revised Special Notice document for additional details. ------------------------------------------------------------------------------------------------------------ This Specia

Gt Ref Id - 119306408

Deadline - Oct 02, 2025

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database